Disclaimer

Please note that the following pages are exclusively reserved for health care professionals in countries with applicable health authority product registrations. To the extent this site contains information, reference guides and databases intended for use by licensed medical professionals, such materials are not intended to offer professional medical advice. Prior to use, please consult device labeling for prescriptive information and operating instructions.

US: CAUTION – Investigational Device. Limited by Federal (or United States) law to investigational use.
Videos

The Unmet Need in Severe Aortic Regurgitation: Are We Ready for TAVI?

The prevalence of valvular heart disease increases with advanced age and, unfortunately, in many patients, it’s underdiagnosed, especially aortic regurgitation. In this presentation recorded for PCR London Valves 2022 Tanja Rudolph raises the question: Are we ready for TAVR in aortic regurgitation?

Latest News

View All
Press
JenaValve Announces Start of Commercialization of the Trilogy<sup>®</sup> Transcatheter Heart Valve System in the US
April 1, 2026
JenaValve Announces Start of Commercialization of the Trilogy® Transcatheter Heart Valve System in the US
Read More
Press
JenaValve Announces FDA Approval of the Trilogy™ Transcatheter Heart Valve System
March 18, 2026
JenaValve Announces FDA Approval of the Trilogy™ Transcatheter Heart Valve System
Read More
Press
New, Late-Breaking Results from the ALIGN-AR Trial Published in The Lancet and Presented at PCR London Valves
November 24, 2025
New, Late-Breaking Results from the ALIGN-AR Trial Published in The Lancet and Presented at PCR London Valves
Read More
Close Download
Close Download
The JenaValve TrilogyTM Heart Valve System Billing Guide contains appropriate coding (e.g. CPT, ICD-10, and HCPCS), coverage, and payment for procedures performed with the JenaValve TrilogyTM Heart Valve System. For additional information, please contact us at reimbursement.usa@jenavalve.com.